Filusch et al. [15] found that a novel hsTnT assay was more effective in detecting cTnT levels in PAH patients, and that elevated hsTnT levels correlated with poor prognosis and other parameters of disease severity. The gene discussed is TNNT2; the disease is pulmonary arterial hypertension.